Pricing

Ocugen

1 follower

‌

Ocugen Inc. (NASDAQ: OCGN) is a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness diseases and developing a vaccine to fight COVID-19.

Industries

Biotechnology

Headquarters

Malvern, United States

Employees

51-200

Links

Org chart

Shankar Musunuri

Chairman, CEO & Co-founder

Shankar Musunuri

Collapse

Arun Upadhyay

Chief Scientific Officer, Head of Research & Development & Medical

Mike Shine

SVP, Commercial

Jyothy Pillai

Head, Regulatory & Quality

Tiffany J. Hamilton

Avp, Head Of Corporate Communications

Daniel Stilp

Senior Accountant

Michael Breininger

Corporate Controller

Teams

Scientific Advisory Team

11 members

Leadership Team

3 members

Finance and Administration Team

6 members

Regulatory and Compliance Team

4 members

Similar companies

Immunovant

5 followers

Pendulum

4 followers

Eikon Therapeutics

1 follower

Nucleate

3 followers

Thermo Fisher Scientific

162 followers

Exact Sciences

15 followers

Cytokinetics

11 followers

Idexx Laboratories

7 followers

Empirico

1 follower

Tessera Therapeutics

2 followers

Kodiak

2 followers

Explore companies